Аустралија - Енглески - APVMA (Australian Pesticides and Veterinary Medicines Authority)

kenso corporation (m) sdn. bhd. - copper (cu) present as tribasic copper sulphate - suspension concentrate - copper (cu) present as tribasic copper sulphate mineral-copper active 190.0 g/l - fungicide

Сингапур - Енглески - HSA (Health Sciences Authority)

merative singapore pte. ltd. - radiology / imaging - cadstream is intended to be used in the visualization, analysis, and reporting of magnetic resonance imaging (mri) studies. cadstream supports evaluation of dynamic mr data acquired during contrast administration. cadstream performs other user selected processing functions (such as image registration, subtractions, measurements, 3d renderings, and reformats). cadstream also includes user-configurable features for reporting on findings in breast or general mri studies. additionally, cadstream assists users in planning mri guided interventional procedures. when interpreted by a skilled physician, this device provides information that may be used for screening, diagnosis, and interventional planning. patient management decisions should not be made based solely on the results of cadstream. cadstream may also be used as an image viewer of multi-modality, digital images, including ultrasound and mammography. cadstream is not intended for primary interpretation of digital mammography images.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

biotronik australia pty ltd - 47270 - biventricular pacemaker/defibrillator - a triple chamber rate adaptive icd, with is4 port connecting a quadripolar lv lead, home monitoring functions, max. shock of 40j and df4/is4/is-1 connector. biocompatible titanium housing is hermetically sealed and serves as a potential antipole during shock delivery or in the case of unipolar lead configuration. ellipsoid shape facilitates implanting in the pectoral muscle area. connections for bipolar pacing, sensing, unipolar connections and shock delivery are in the header. mr conditional. rivacor 7 hf-t qp belongs to a family of implantable cardioverter-defibrillators (icds). the primary objective of the therapy is to prevent sudden cardiac death. furthermore, the device is capable of treating bradycardia arrhythmias and cardiac resynchronization therapy with multisite ventricular pacing. the implantation of an icd is a symptomatic therapy with the following objectives: ?termination of spontaneous ventricular fibrillation (vf) through shock delivery ?termination of spontaneous ventricular tachycardia (vt

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

allergan australia pty ltd -

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - galantamine (galantamine hydrobromide) - solution for injection - 2,5mg/ml

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - galantamine (galantamine hydrobromide) - solution for injection - 1mg/ml

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - galantamine (galantamine hydrobromide) - solution for injection - 5mg/ml

Арменија - Енглески - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

sopharma jsc - galantamine (galantamine hydrobromide) - solution for injection - 10mg/ml

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; sodium hydroxide; water for injections - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

specialites septodont pty ltd - lidocaine hydrochloride monohydrate, quantity: 20 mg/ml; adrenaline (epinephrine), quantity: 12.5 microgram/ml (equivalent: adrenaline (epinephrine) acid tartrate, qty 22.8 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; potassium metabisulfite; disodium edetate; water for injections; sodium hydroxide - indications as at 17 july 2003: lignocaine solutions are indicated for the production of local anaesthesia in routine procedures and oral surgery by means of infiltration and nerve block techniques. lignocaine solutions with adrenaline are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.